GeneThera Inc (GTHR)
0.00
USD |
OTCM |
May 24, 16:00
GeneThera Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2008 | -0.0561 |
| December 31, 2007 | -0.1124 |
| September 30, 2007 | -0.1049 |
| June 30, 2007 | -0.1163 |
| March 31, 2007 | -0.1095 |
| December 31, 2006 | -0.1168 |
| September 30, 2006 | -0.2993 |
| June 30, 2006 | -0.0356 |
| March 31, 2006 | -0.2176 |
| December 31, 2005 | -0.1989 |
| September 30, 2005 | -1.268 |
| June 30, 2005 | -6.885 |
| March 31, 2005 | 0.5768 |
| December 31, 2004 | -1.124 |
| September 30, 2004 | -1.888 |
| June 30, 2004 | -0.5795 |
| March 31, 2004 | 79.71 |
| Date | Value |
|---|---|
| December 31, 2003 | -0.4638 |
| September 30, 2003 | -0.6323 |
| June 30, 2003 | -0.5831 |
| March 31, 2003 | -0.6937 |
| December 31, 2002 | -0.2059 |
| September 30, 2002 | -0.8938 |
| June 30, 2002 | -0.4543 |
| March 31, 2002 | -0.4854 |
| December 31, 2001 | -7.340 |
| September 30, 2001 | 0.4416 |
| June 30, 2001 | -7.489 |
| March 31, 2001 | 2.340 |
| December 31, 2000 | 0.007 |
| September 30, 2000 | 1.748 |
| June 30, 2000 | 1.388 |
| March 31, 2000 | 0.8977 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.5332 |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 0.6856 |
| Electromed Inc | 0.00 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.0013M |
| Total Liabilities (Quarterly) | 8.543M |
| Shareholders Equity (Quarterly) | -8.541M |